Copyright
©The Author(s) 2019.
World J Clin Oncol. Mar 24, 2019; 10(3): 136-148
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.136
Table 3 Table of chi-square test of association correlating fibroblast growth factor receptor 4 expression, lymph nodes and therapy
| Fibroblast growth factor receptor 4 expression | |||||
| low | high | n | P-value | ||
| Lymph nodes | N0, N1 and N2 | 479 | 459 | 938 | 0.0001 |
| N3 | 117 | 58 | 175 | ||
| Chemotherapy | No | 403 | 269 | 672 | 0.0001 |
| Yes | 193 | 248 | 441 | ||
- Citation: Wimmer E, Ihrler S, Gires O, Streit S, Issing W, Bergmann C. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World J Clin Oncol 2019; 10(3): 136-148
- URL: https://www.wjgnet.com/2218-4333/full/v10/i3/136.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i3.136